Biobanks are important infrastructures to support clinical research and developments in personalized medicine. Although biobanking is not a new invention it has gained importance in the last few years due to increased quality requirements for biological samples in biomedical research and new high resolution Omicstechnologies. Moreover, quality-assured collection, processing and storage of biological samples with defined pre-analytical history plays a key role for reproducibility in scientific research and paves the path towards precision medicine. Due to the increasing need for large numbers of samples, both in basic as well as in translational research, particular attention must be paid to sample acquisition and preparation in order to guarantee the highest possible sample quality. This can be achieved by following best practices or implementation and operation of specific biobank quality management systems that are compliant with the new DIN EN ISO 20387. Moreover, automation of critical process steps in biobanking can help to reach the highest quality standard and consistent sample quality. The following article will present and discuss currently available solutions for process automation in biobanking.
Introduction
Biobanking in the context of clinical research has become increasingly important in the last few years. Already in 2009, the Time Magazine had described biobanks for medical research as one of 10 ideas that will change the world [1] in the near future. Since then, it has become increasingly clear that availability of high-quality samples is an indispensable prerequisite for high-quality biomedical research. Several studies have shown the huge impact of small variations in the pre-analytical workflow on data obtained from biosample analysis, particularly when using new Omics technologies. Quality-assured collection of biological samples thus plays a key role in the value chain of reproducible scientific research and is mandatory to achieve significant developments in the field of precision medicine. However, difficulties have been reported in obtaining biospecimens of adequate numbers and quality when samples were collected in "conventional" ways under heterogeneous, non-standardized conditions [2] . Moreover, lack of adequate biospecimen quality and subsequent irreproducibility of research results can lead to high economic damage [3] .
Due to the challenges mentioned above, biosamples should be collected in the framework of biobanks, where processes ought to be standardized, harmonized and quality controlled to the highest possible quality level. This can be achieved by implementation and operation of specific biobank quality management systems that are compliant with the new DIN EN ISO 20387 introduced recently. In addition this can also be supported by implementation of a range of technical solutions, particularly by automation of critical process areas in biobanking.
Based on a brief description of the process steps relevant for liquid biobanking, the following section will present and discuss possible solutions to ensure process quality, by means of standardization and automation in biobanking in order to provide an up-to-date insight into the opportunities and challenges of establishing highly automated biobanks.
Processes in biobanking
Sampling, transport, reception, processing, storage, retrieval
The entire pre-analytical workflow is of particular importance for the quality of biological samples [4] [5] [6] . The term pre-analytics encompasses a number of processes ( Figure  1) , including sample selection, sampling, sample transport, sample processing and storage, as well as sample recovery and distribution to specific research projects. Compared to well-established and highly controlled analytical and post-analytical processes in the workflow, all pre-analytical process steps are highly susceptible to errors [7] [8] [9] . Various studies have shown that almost all areas of pre-analytics can influence quantification of various molecules and thus have a high impact on the analytical phase [10] [11] [12] .
Basically, biological/environmental interfering factors (individual factors) can be distinguished from technical interfering factors [5, 13] . Individual factors lead to concentration changes of analytes in vivo independent of the analytical method used for their quantification [5, 13] . In the context of clinical and epidemiological studies such individual factors are documented in order to be able to estimate their effects on subsequent analysis. In medical care, only those individual factors that potentially have the greatest influence on the results of measurements (e.g. age, gender, fasting status) are usually documented. Technical factors, such as transport (temperature, time, transport system, etc.), processing (manual, automatic, temperature, time, etc.) and storage (time, temperature, freeze-thaw cycles, etc.), leading to in vitro interference, also play an important role [5, 6] . A big issue is the high heterogeneity of the pre-analytical factors described above, in the different working environments (e.g. populationbased biobanking vs. healthcare-integrated biobanking) or at different locations, particularly in multicenter trials. Thus, specific requirements might also result in different working protocols and standardized operating procedures (SOPs). The aforementioned difficulties might be overcome by first, quality control and harmonization and second by automation, of as many as possible critical process steps at different study sites, to ensure comparability of sample quality, e.g. in larger network projects [14] .
Harmonization of process steps to ensure comparable quality in biobanking
Harmonization can be achieved by different methods, e.g. by adaption of SOPs at different locations according to a master SOP agreed upon in a certain research network, which might at least lead to a better comparability of a certain sample quality. However, those harmonization processes might not be completely evidence-based and often rest only on subjectively agreed "best practice" conditions. Best practice documents can be provided by expert associations, regional institutions or in specific networks and may be very diverse. Moreover, all key steps of the process and deviations from the SOPs must be documented in order to identify possible sources of errors. Monitoring of process steps and corresponding deviations is often time consuming as automated data collection is only possible to a very limited extent. Another constraint is that site-specific framework conditions must always be taken into account. For example, unavailability of personnel for 24/7 sample acceptance can lead to delays in sample-processing and deviation from harmonized SOPs due to a lack in infrastructure. Even though harmonization might be successfully accomplished, it can only be the first step on the way to an optimized and consistent high sample quality.
Necessity of standardization
Besides harmonization, based on best practice guidelines, international standards are needed to ensure comparable, optimized sample quality [15] . The standard DIN EN ISO 20387:2018 "Biotechnology -Biobanking -General requirements for biobanking" was recently published. This standard defines "general requirements, including, e.g. requirements for competence in quality control, impartiality and consistency of biobanking operations, to ensure appropriate quality of sample collections" [16] . For the first time, notified bodies can now confirm that a biobank has the competence to carry out biobank tasks in accordance with the new DIN EN ISO 20387. This will significantly advance the development of biobanking, international standardization and thus collection, storage and distribution of biosamples with equivalent high quality. Detailed information about the development and implementation of the standard can be obtained from the article by Meinung et al. in this special issue. Chapter 7 of the published standard defines process requirements for transport, preparation, preservation, storage and distribution of biological materials. All of these process steps are very complex and laborious when performed manually and, when compared to automated procedures, are subject to higher error rates. Therefore, interest in the implementation and application of automated solutions for standardization of various biobank processes has increased considerably in recent years.
Automation as a tool for the standardization of biobank processes
One way to promote standardization and thus to limit, eliminate or fully control the technical factors influencing sample quality is the use of automation which can provide any one or all of the following advantages: -flexible and fast process adaptation -reduction of error susceptibility -continuous availability -automated documentation of process steps at individual sample level -personnel savings, with stable functionality of the system -simplification of workflows -minimization of manual process steps -increased transparency of workflows -continuous traceability of individual samples However, in addition to the above-mentioned advantages, some aspects of automation could also present barriers and challenges that must also be taken into account. For example, automation, particularly in the context of multicenter studies, requires comparable devices (e.g. barcode readers, liquid handling platforms, etc.), adapted to specific tube formats, interfaces and data formats used throughout the study to ensure comparable tube handling and data exchange. Moreover, special requirements of, e.g. automated storage systems (see below) with regard to space and technical conditions (load, nitrogen supply, exhaust air, heat dissipation, etc.) have to be considered. Also, the additional costs for procurement and maintenance (service and repair) of such systems are to be calculated while planning the infrastructure. In addition, the operating costs and the costs for consumables can be higher than for manual processes. Although automation might save on personnel, the personnel who operates the systems has to be trained and, in the case of new developments and innovations, also to be re-trained. One of the major challenges with regard to automated handling of biosamples from different biobanks with the aim to combine bioresources is the use of different storage formats (e.g. cryotubes, straws) or storage strategies (e.g. −80 °C, vapor phase of liquid nitrogen [vplN 2 ]). This can also be disadvantageous, especially for old sample collections within a biobank. The aforementioned aspects can considerably hinder the cooperation and interoperability between biobanks.
There are almost no limits for automation of biobank processes, with the exception of the sample collection itself. Nearly all pre-analytical processes, particularly for liquid samples, can be automated nowadays. However, in the field of tissue biobanking some process steps are not suitable for automation, e.g. tissue sampling and partitioning (with the exception of robot-assisted surgical methods).
A prerequisite for the automation of the entire process is the unambiguous assignment of the samples in order to avoid sample mix-ups. The 2D barcoded tubes, widely used in the field of biobanking, offer a good option of unambiguous assignment. However, this also requires systems that allow capturing of 2D barcodes with special barcode readers. Almost all systems for automated processing and storage of biosamples offer built-in or retrofittable solutions for capturing 2D barcodes.
Automation of transport
Automation of the transport of biological samples from peripheral facilities or pre-analytical laboratories to the biobank has several advantages over manual sample transport, particularly 24/7 availability without excessive personnel cost and reduced turnaround time [17] . For this purpose, validated pneumatic tube systems can be applied for transportation of single samples (e.g. Tempus600) as well as of a collection of several sample vials (e.g. Aerocom) from outpatient clinics or wards to pre-analytical laboratories, biobanks or clinical routine labs. However, care must be taken to ensure that acceleration and deceleration forces on samples during transport are kept to a minimum to avoid sample hemolysis and thus release of certain analytes, e.g. from blood cells, as well as interference with subsequent analytical methods [18] .
Today, transport within laboratories can be automated easily. The movement of sample tubes within the laboratory is performed by automated peri-analytic systems, connecting pre-analytical workstations with several individual analytical instruments and sample archives. The transport can be realized both passively, by the use of conveyor belts, as well as by active movement of the samples on so-called "CARs", small actively moving sample carriers. Such laboratory lines play an important role in healthcare-integrated biobanking. Two different scenarios might support researchers and biobankers for sample collection. In scenario 1, sample preparation for biobanking can be requested directly via order-entry systems, in parallel to the routine laboratory workflows. In this case, samples are taken directly from the laboratory line to the connected aliquoting module, where the requested number of aliquots are processed. With scenario 2, automated biobanking can be carried out on the basis of specific sample characteristics as defined by certain laboratory values. Selection of samples for biobanking is thus induced after measurement of corresponding laboratory parameters. If a specific parameter constellation is suitable, the remaining sample is routed to the aliquoting module for sample processing and subsequent biobanking. This scenario can be applied also for the selection of samples that meet certain quality criteria (e.g. HIL check).
Automated sample processing
In the last few years, several systems have been developed to support various automated sample processing steps in the biobanking workflow. These range from simple processes such as sample aliquotation (e.g. systems from Tecan, Hamilton, Cryo Bio Systems-IMV, Sarstedt) to complex workflows, e.g. separation of buffy coat, isolation of nucleic acids and automated processing of peripheral mononuclear blood cells (PBMCs).
For processing of nucleic acids, different systems with various capacities supporting different extraction methods are available, ranging from magnetic beads based to precipitation methods using centrifuges. The degree and extent of manual support of these systems is arbitrarily scalable. The quality of nucleic acids isolated by the different technologies is comparable; however, all have their justification [19] .
In the process of automated aliquoting, special attention must be paid to the tube format. In most cases, Society for Biomolecular Screening (SBS) rack-formatted cryotubes are used. Although tubes with different diameters and heights can be accommodated in this format, automated workflows are often restricted to only a few formats, as every subsequent process step has to be adapted to the preferred tube format. For example, if automation goes beyond the mere aliquoting process and includes opening and closing of the primary and the aliquot tubes without manual support, special attention has to be paid to the format of the screw caps, which might be also compatible with tools for automated picking and placing of tubes. Moreover, robots of some companies are capable of detecting different phases in biological samples (e.g. serum/plasma, buffy coat, red blood cells) which can then be separated automatically from each other during the aliquoting process. Besides SBS-formatted tubes, other sample formats, such as straws (e.g. DIVA from Cryo Bio Systems-IMV), can also be filled automatically. In this case, the first step is to label the straws using a printer. The straws are then filled, hermetically sealed and sorted according to a pre-defined scheme.
Automated freezing
The process of sample freezing plays an important role either with regard to sample integrity for some biosamples and/or performance of analytical methods applied following sample storage.
Ideally, sample freezing should occur immediately after sample aliquoting. However, these requirements are often difficult to meet, particularly in the setting of healthcare-integrated biobanking with discontinuous sample workflows. To enable standardized sample processing even under these conditions, automated sample aliquotation systems have been developed that either allow aliquoting and sample freezing in one step, by pipetting in 2D barcoded tubes located in an −20 °C pre-cooled sample container (Figure 2A ) or by transfer of single tubes in a −20 °C environment, to so-called on-deck freezers, for sample freezing, immediately after aliquoting ( Figure 2B ). In some systems SBS racks were transferred in −20 °C freezers located below/beneath the pipet-robot, not before complete aliquoting of a complete rack. However, this workflow has the disadvantage of unequal sample treatment particularly with regard to differences in time to freeze (TTF). As TTF differences increase the more discontinuous the sample flow is, such systems should not be used in situations with small sample numbers over time.
Controlled freezing is also essential for cryopreservation of cells. Cooling rates of −1 °C/min can be achieved by manual systems. However, there are also automated systems that carry out the cooling process in a controlled manner using optimized freezing protocols with a direct detection of the actual temperature of the samples. After completion of the automated freezing process, samples can be transferred by using dry ice/liquid nitrogen to the final storage device. The main advantage of such systems is the higher cell-viability compared to the standard isopropyl alcohol protocol [20] .
Automated storage
Non-automated ultra-low-temperature freezers have the disadvantage of substantial temperature fluctuations due to sample handling when opening the freezers, leading to temperatures differing from the set temperature of −80 °C [21, 22] . While the coldest area inside a standard freezer is located in the back area of the middle or lower shelf, where the temperature sensor is located, the warmest spot is mostly in the front area of the upper shelf [22] . On the contrary, automated storage systems show a uniform temperature with minimal deviations to the set temperature.
In modern clinical laboratories, automated archiving systems for storage of routine samples at 4 °C for a predefined period of time are commonly an integral part in the setting of laboratory automation. Although the mechanical requirements for automation become more and more complex as the temperature decreases, several automated systems listed below, that allow for automated sample storage at −80 °C and below −150 °C, are available (Table 1) .
Currently, there are several automated biobank systems that can store samples at −80 °C or in the vapor phase of LN 2 at even lower temperatures (Figure 3 ). Such systems often contain basically three different temperature zones. The major components of the robotic are often located in areas far above the actual storage zone at temperatures between 0 °C and −20 °C. Thus, those parts of the actively operating robotic components that are directly involved in sample handling or picking, only briefly work at temperatures between −60 °C and −100 °C. Keeping the mechanical components at temperatures above −20 °C has the advantage of improved function and durability so that the whole automated storage system can work properly for longer time periods. A second advantage is reduced thermal transfer from mechanical components to the samples. The second temperature zone is the area of sample picking and placing for selection and prepackaging of sample subsets. Samples should be located in these areas as short as possible if [A]-[F] in the column "system" refers to the illustrations in Figure 3 . the handling temperatures, which are in the temperature range between −20 °C and −100 °C depending on the respective system, differ from the storage temperatures. The last zone is the storage zone, where long-term storage of samples takes place, usually at −80 °C or below −150 °C. This area is actively cooled using liquid nitrogen, compressors, or both, e.g. in the backup situation. Some systems have several compressors and in addition a final LN 2 as backup so that cooling is not interrupted under any circumstances. Total storage capacity of −80 °C systems is often more adaptable and larger than that of LN 2 systems currently on the market.
The choice of the storage temperature depends on several aspects, including planned duration of storage, type of sample material, the intended use of the biosamples, access speed for sample recovery and spatial and technical conditions. Actually there is no preference for one or the other storage temperature for a storage time of up to 6-7 years as for different kinds of biomarkers no changes have been observed at −80 °C [23] [24] [25] . However, particularly for metabolites it has been shown that 26% of 236 metabolites analyzed in a recent study changed their concentration within storage times of up to 16 years at −80 °C [25] . Nevertheless, up to now it is unclear whether storage at temperatures below −80 °C could prevent these effects. Moreover, recent data have shown an association of bilirubin derivatives particularly with long-term storage at vpLN 2 in straws compared to storage at −80 °C, indicating that specific changes may also occur for this type of storage (personal communication). Basically, the more unpredictable the later use of the sample and the longer the sample is to be stored, the more advisable it is to store it at very low temperatures. However, there is still the debate about pros and cons of storage conditions with insufficient evidence about the advantages of storing liquids at temperatures below −80 °C for standard applications and storage time of up to several years (see above).
In addition to the storage temperature, the handling temperature is also decisive. This temperature should correspond to the storage temperature or should be kept as low as possible in order to minimize freeze-thawing events as well as crystalline transformation of the samples. Thus, it must also be ensured that the glass transition temperature of approx. −135 °C [26] is not exceeded during sample storage and handling of samples stored in the vapor phase of LN 2 , to avoid recrystallization processes. Additionally, the water in the sample should be kept in the solid state due to the potential for acting to degrade the biological molecules that might have negative consequences for the downstream analysis [26] .
It should also be considered that for automated handling and picking of sample vials, specific tools adapted to the geometry of the screw cap of the individual vials are required. As the diameter of the tubes is thus usually unchangeable, only the tube height might be de-/or increased to adapt storage volume of individual devices.
Technical requirements also lead to limitations in the use of straws in automation. Due to the hermetic sealing at both ends, individual automated handling of these sample vials is currently not possible. Thus, the smallest automatable unit is the collection vessel of the straws, the so-called goblet, containing a multiplicity of individual straws.
Automation of systems is sometimes scalable, from simple handling of single drawers in the basic version to cherry picking of individual samples up to interconnecting several devices to a fully automated system ( Figure 4 ). Moreover, individual cryocontainers can be combined to build up a fully scalable large cryostore facility, as realized in recent years for the central biorepository of the German National Cohort at the Helmholtz Zentrum München.
Post biobanking automation
Biobanks store samples until they are requested by researchers for certain projects. Individual sample subsets can be composed for individual projects by automated picking at temperatures ranging from −20 °C up to −100 °C depending on the storage devices used. In case of special research questions, individual biobanks might provide only parts of the required biological samples. If researchers then have to combine samples from different biobanks, interoperability of biobanks is mandatory. However, interoperability might be hampered if biobanks are using different storage formats, characterized by different, e.g. screw caps and barcode labels, requiring tools for automated sample handling that are not commonly available and implemented at certain biobank or research sites. Besides laborious manual sample handling, modern aliquoters can also be helpful in such situations if such a robot can open and process as many sample formats as possible. However, systems with corresponding functions are currently not or only partially available. Another problem is the use of straws, due to the fact that there is currently no system on the market that allows automated opening and sample recovery, and thus straws have to be processed manually.
For some applications a controlled thawing of the samples might be necessary. The automatic freezers described above can also be used for such thawing processes.
Summary
Pre-analytical variables play an important role in all biobanking-associated processes. Due to advances in analytical methods and the actual developments in the field of precision medicine, such influences have to be minimized. Harmonization of biobank processes based on the framework of the new DIN EN ISO 20387:2018 as well as guidelines and best practices, provided by experts and professional societies (ISBER, ESBB, European Union) in combination with implementation of extensive quality control and quality management systems will build the basis of high-quality biobanking.
Automation of individual biobank processes can be effective to minimize the influence of pre-analytical variables. The many years of experience in automation in the context of laboratory medicine and the involvement of clinical routine labs helps to implement automated workflows also in the field of biobanking. Lessons learned include, e.g. definition of formats of sampling systems that will feed into the automated processing systems, integration of different systems in one streamlined workflow, implementation and monitoring of automationassociated data flows, validation of processes and quality assessment as well as quality control of automated workflows. Moreover, integration or close association of liquid biobanks with clinical routine laboratories, already characterized by a high degree of automation, has also the advantage of 24/7 availability, personnel savings due to lower binding of technical staff for manual processes, the existence of and experience with already implemented quality control systems (DIN EN ISO 15189 and DIN EN 17025) as well as the experience in daily handling of large amounts of samples in the routine workflows. In addition, well-established automated transport within and to the clinical laboratory can also be a good model for implementation of corresponding processes in biobanking.
An important part of biobanking is the storage system. Automation in this area has great advantages. Due to optimized workflows, frequent temperature fluctuations during storage, transfer and retrieval of samples can be avoided. It is important that the temperature during sample handling is as close as possible to the storage temperature. This not only saves energy but can also have positive effects on sample quality [27] .
Another important aspect is related to the efficient use of storage space. Automated storage offers the possibility of defragmentation and thus efficient use and optimization of storage space. This is becoming increasingly important due to the dynamic processes in biobanks [28] . Current systems offer different combinations of storage and handling temperatures ( Table 1) . Suitable combinations have to be used based on the specific requirements, e.g. duration of storage, type of sample material and intended use, access speed for sample recovery and spatial and technical conditions. In general, there is currently hardly any literature that shows an advantage of storage in vpLN 2 on the biostability and thus the quality of liquid biosamples. However, storage in vpLN 2 has an advantage for the safety of the samples. Even after a power failure and in case of problems with the nitrogen supply, the samples are safe for up to 3 days. This provides enough time to initiate appropriate measures. The same holds true for modern automated −80 °C systems offering comprehensive backup options, with one or two backup compressors and in case of failure of these backups or power blackout a temporary emergency cooling with liquid nitrogen. Nevertheless, if possible, not all samples should be stored at the same location. A redundant storage concept is particularly important in the event of a fire or other catastrophes. A further advantage of automated systems is the possibility of seamless tracking of samples and sample access. By logging on to the respective systems, sample security against unauthorized access can also be guaranteed [29] .
With regard to interoperability, e.g. when samples have to be combined from different biobanks, problems can arise due to different consumables. Interoperability is often complicated by adaptation of the automated systems to the consumables, e.g. design of the tubes and their respective caps and barcodes, used at the different biobanks although the different manufacturers have decided on a basic storage structure (SBS rack). This often leads to incompatibility especially in systems for sample picking, which is often aligned to a specific geometry of the lid.
Automation solutions offer many advantages that clearly outweigh the existing disadvantages, e.g. costs vs. benefits only, if they are well planned and fit the need of the intended use. This must be carefully considered before deciding on the implementation of automation in biobanking. Unfortunately, there are still gaps at the interfaces between the different automated components. For example, transfer points from systems for aliquotation to systems enabling sample freezing and from there or directly to the storage systems would be very desirable. However, these gaps will certainly be closed in the near future, leading to optimized and continuous process chains in the automated biobanking workflows.
